Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mauricio Catala
Treatment of High-Grade Glioma Patients With the Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Antibody H-R3: Report From a Phase I/Ii Trial
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Related publications
Phase II Trial of Anti-Epidermal Growth Factor Receptor Radioimmunotherapy in the Treatment of Anaplastic Astrocytoma
Journal of Radiation Oncology
Oncology
Radiology
Nuclear Medicine
Imaging
Phase I Study of Tomuzotuximab, a Glycoengineered Therapeutic Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Carcinomas
ESMO Open
Cancer Research
Oncology
BRAF; Epidermal Growth Factor Receptor (EGFR)
Science-Business eXchange
A Phase I Study of Farletuzumab, a Humanized Anti-Folate Receptor Α Monoclonal Antibody, in Patients With Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Epidermal Growth Factor Receptor in Human Glioma
Journal of Neurosurgery
Surgery
Neurology
Cetuximab and Platinum-Based Chemoradio- Or Chemotherapy of Patients With Epidermal Growth Factor Receptor Expressing Adenoid Cystic Carcinoma: A Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Structural Characterization of a Potent Humanized Anti-Cd38 Antibody in Phase I
Acta Crystallographica Section A: Foundations and Advances
Materials Science
Condensed Matter Physics
Theoretical Chemistry
Biochemistry
Structural Biology
Inorganic Chemistry
Physical
Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis in Adenocarcinoma of Lung, the First Report From Iran
